{
  "num_tested_probands": [
    3,
    3,
    1
  ],
  "num_positive_het_probands": [
    1,
    1,
    1
  ],
  "positive_phenotypes": [
    [
      "prolonged duration of action of succinylcholine"
    ],
    [
      "prolonged duration of action of succinylcholine",
      "apnoea",
      "postoperative artificial ventilation"
    ],
    [
      "Response to mivacurium"
    ]
  ],
  "num_compound_or_double_hets": [
    1,
    2,
    1
  ],
  "quote_snippets": [
    [
      "We present three novel mutations in the butyrylcholinesterase gene (BCHE) identified in three families in which a member had experienced severely prolonged duration of action of succinylcholine:",
      "The proband in family was genotyped as BCHE*115D*I3E4-14C/BCHE*FS126, whereas the proband in family 3 was compound heterozygous for BCHE*328D and BCHE*142M.",
      "In both patients, BChE activity was below detection limit; and they experienced an extensively prolonged duration of action of succinylcholine:"
    ],
    [
      [
        "The proband in family 3 (Table 1, patient 3) was com-",
        "pound heterozygous for BCHE*328D and BCHE*142M, the latter mutation also known a8 the H-variant."
      ],
      [
        "The proband in family 1 (Fig: 1, patient 1-2) had the genotype BCHE*H15D*I3E4-I4CIBCHE*FS126 and dis-",
        "played prolonged duration of action of succinylcholine resulting in 3 hours of apnoea and hence postoperative artificial ventilation at the intensive care unit."
      ],
      [
        "The mutation BCHE*FS126 also occurred in the unrelated family 2 (Table 1). One patient with a low BChE activity was genotyped as heterozygous for BCHE*FS126 (Table 1, patient 2-3)_"
      ]
    ],
    [
      [
        "Response to mivacurium in patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene-Genotyping by sequencing"
      ]
    ]
  ],
  "cleaned_quotes": [
    [
      "We present three novel mutations in the butyrylcholinesterase gene (BCHE) identified in three families in which a member had experienced severely prolonged duration of action of succinylcholine.",
      "The proband in family was genotyped as BCHE*115D*I3E4-14C/BCHE*FS126, whereas the proband in family 3 was compound heterozygous for BCHE*328D and BCHE*142M.",
      "In both patients, BChE activity was below detection limit, and they experienced an extensively prolonged duration of action of succinylcholine."
    ],
    [
      "The proband in family 3 (Table 1, patient 3) was com-",
      "pound heterozygous for BCHE*328D and BCHE*142M, the latter mutation also known as the H-variant.",
      "The proband in family 1 (Fig: 1, patient 1-2) had the genotype BCHE*H15D*I3E4-I4CIBCHE*FS126 and dis-",
      "played prolonged duration of action of succinylcholine resulting in 3 hours of apnoea and hence postoperative artificial ventilation at the intensive care unit.",
      "The mutation BCHE*FS126 also occurred in the unrelated family 2 (Table 1). One patient with a low BChE activity was genotyped as heterozygous for BCHE*FS126 (Table 1, patient 2-3)."
    ],
    [
      "Response to mivacurium in patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene-Genotyping by sequencing"
    ]
  ],
  "gene_symbol": [
    [
      "BCHE",
      "CLU",
      "DCR",
      "FST",
      "S12",
      "ST2",
      "UST"
    ],
    [
      "BCHE",
      "C5",
      "CAT",
      "CHE2",
      "GC",
      "PC",
      "S12",
      "S19"
    ],
    [
      "BCHE"
    ]
  ],
  "genomic_hgvs": [
    [],
    [],
    []
  ],
  "explanation": {
    "num_tested_probands": [
      "The report presents three novel mutations identified in three families, each with a proband experiencing prolonged action of succinylcholine.",
      "The probands discussed are in family 1 (patient 1-2), family 2 (patient 2-3), and family 3 (patient 3).",
      "A single patient is mentioned: 'in patient compound heterozygous for a novel and a known silent mutation.'"
    ],
    "num_positive_het_probands": [
      "One proband in family 1 is reported as compound heterozygous for BCHE*115D*I3E4-14C/BCHE*FS126.",
      "Family 2 has one patient with low BChE activity genotyped as heterozygous for BCHE*FS126.",
      "The same patient is compound heterozygous, implying they are heterozygous for both mutations: 'in patient compound heterozygous for a novel and a known silent mutation.'"
    ],
    "positive_phenotypes": [
      "The proband in family 1 experienced a severely prolonged duration of action of succinylcholine.",
      "Phenotypes such as 'prolonged duration of action of succinylcholine, apnoea, and hence postoperative artificial ventilation' described for probands with heterozygous mutations.",
      "The phenotype 'Response to mivacurium' is associated with the patient: 'Response to mivacurium in patient compound heterozygous...'"
    ],
    "num_compound_or_double_hets": [
      "The text explicitly mentions one proband in family 3 who is compound heterozygous for BCHE*328D and BCHE*142M.",
      "Two patients are reported as compound heterozygotes: proband in family 3 (patient 3) and proband in family 1 (patient 1-2).",
      "The text explicitly states: 'in patient compound heterozygous for a novel and a known silent mutation,' indicating one compound heterozygote."
    ]
  }
}